News for Syros Pharmaceuticals Stock (SYRS)

The Schall Law Firm Urges Investor Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • 3h

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders Are Encouraged To Contact The Schall Law Firm

Accesswire • Tuesday

The Schall Law Firm Urges Investor Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • Monday

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/27/24

The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • 10/24/24

Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

Business Wire • 10/24/24

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/23/24

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/21/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/19/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/15/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Encouraged To Reach Out To The Schall Law Firm

Accesswire • 10/13/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/09/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/03/24

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • 10/02/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Investors Are Invited To Contact The Schall Law Firm

Accesswire • 10/01/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Assist The Schall Law Firm

Accesswire • 09/29/24

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS

Accesswire • 09/29/24

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • 09/28/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Investors Are Urged To Assist The Schall Law Firm

Accesswire • 09/27/24

The Schall Law Firm Invites Shareholders To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Violating Securities Laws

Accesswire • 09/26/24

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire • 09/25/24

The Schall Law Firm Encourages Shareholders With Losses In Syros Pharmaceuticals, Inc. To Join An Inquiry For Securities Law Violations

Accesswire • 09/24/24

Syros Pharmaceuticals Inc Is Being Looked Into For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire • 09/23/24

The Schall Law Firm Encourages Shareholder Participation In An Investigation Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • 09/22/24

Investors Are Urged To Join The Schall Law Firm In A Securities Fraud Inquiry Into Syros Pharmaceuticals Inc

Accesswire • 09/21/24